Back to Search
AASIF KAZI, M.D.
M.D.
Otolaryngology Physician
NPI: 1497169221IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pharmacist
Pharmacist
Code: 183500000X
RPH 024880(GA)
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
0116030998(VA)LM751(CA)
CMS Specialties
PrimaryOTOLARYNGOLOGY
Education
MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Class of 2014
Research & Publications (20)
Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells.
PMID 19471122·Cell Cycle·2009
7-preclinical
Blockade of protein geranylgeranylation inhibits Cdk2-dependent p27Kip1 phosphorylation on Thr187 and accumulates p27Kip1 in the nucleus: implications for breast cancer therapy.
PMID 19204084·Mol Cell Biol·2009
7-preclinical
Novel N-thiolated beta-lactam antibiotics selectively induce apoptosis in human tumor and transformed, but not normal or nontransformed, cells.
PMID 14698048·Biochem Pharmacol·2004
8-other
Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent.
PMID 14633511·Am J Physiol Lung Cell Mol Physiol·2004
8-other
Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein.
PMID 12963483·Biochem Pharmacol·2003
8-other
A natural musaceas plant extract inhibits proteasome activity and induces apoptosis selectively in human tumor and transformed, but not normal and non-transformed, cells.
PMID 14612961·Int J Mol Med·2003
8-other
Inhibition of bcl-x(l) phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis.
PMID 12237322·Mol Pharmacol·2002
8-other
VEGF, fetal liver kinase-1, and permeability increase during unilateral lung ischemia.
PMID 10956620·Am J Physiol Lung Cell Mol Physiol·2000
7-preclinical
Binding of peroxiredoxin 6 to substrate determines differential phospholipid hydroperoxide peroxidase and phospholipase A(2) activities.
PMID 19236840·Arch Biochem Biophys·2009
7-preclinical
Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer.
PMID 19351752·Clin Cancer Res·2009
3-trial
Health burden of skin lesions at low arsenic exposure through groundwater in Pakistan. Is river the source?
PMID 19419713·Environ Res·2009
8-other
Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus.
PMID 19420388·Biol Reprod·2009
7-preclinical
Mitogen-activated protein kinase-mediated phosphorylation of peroxiredoxin 6 regulates its phospholipase A(2) activity.
PMID 19140803·Biochem J·2009
7-preclinical
Molecular markers based identification of diversity for drought tolerance in bread wheat varieties and synthetic hexaploids.
PMID 19430030·Curr Issues Mol Biol·2009
8-other
Oxidant stress stimulates expression of the human peroxiredoxin 6 gene by a transcriptional mechanism involving an antioxidant response element.
PMID 18973804·Free Radic Biol Med·2009
7-preclinical
Role of P63 (CKAP4) in binding of surfactant protein-A to type II pneumocytes.
PMID 18708633·Am J Physiol Lung Cell Mol Physiol·2008
7-preclinical
Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribonucleoside prevents leucine-stimulated protein synthesis in rat skeletal muscle.
PMID 18806097·J Nutr·2008
7-preclinical
Semi-empirical procedures for correcting detector size effect on clinical MV x-ray beam profiles.
PMID 19070247·Med Phys·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 450 SUTTER ST RM 933
SAN FRANCISCO, CA 94108 - Phone
- (415) 362-5443
Quick Facts
- NPI
- 1497169221
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile